Early TAVR


To establish the safety and effectiveness of the Edwards SAPIEN 3 (Edwards Lifesciences, Irvine, California) Transcatheter Heart Valve (THV) compared with clinical surveillance (CS) in asymptomatic patients with severe, calcific aortic stenosis

Primary Investigator: Peter Mason, MD
Subinvestigator: Paul Pearson, MD; Joshua Meskin, MD; Marc Lazzaro, MD; Panayotis Fasseas, MD

Status: Currently enrolling